SEARCH RESULTS FOR: "Tag: PFE"
loading image
REFINE YOUR SEARCH:
RECENT
Last Week(1)
Last Month(4)
ARTICLES/BLOGS
2023(7)
2022(12)
2021(40)
2020(58)
2019(14)
2018(19)
2017(23)
2016(40)
2015(22)
2014(4)
CATEGORIES
5-Minute Market Rundown(16)
Analyst Downgrades(3)
Analyst Update(8)
Analyst Upgrades(2)
Bernie's Content(1)
Best and Worst Stocks(1)
Buzz Stocks(48)
Earnings Preview(6)
Editor's Pick(1)
Expectational Analysis(1)
Ezines(10)
General(4)
Indicator of the Week(1)
Intraday Option Activity(20)
Market Recap(29)
Midday Market Check(27)
Opening View(61)
Quantitative Analysis(1)
Stock Market News(5)
Stocks On the Move(12)
Strategies and Concepts(1)
The Week Ahead(15)
Trader Content(1)
Unusual Trading Activity(1)

1/31/2023 10:18 AM
Pfizer Inc. (NYSE:PFE) is down 0.8% to trade at $43.22, despite reporting better-than-anticipated fourth-quarter earnings of $1.14 per share, in addition to record revenue of $100.3 billion in 2022....
1/27/2023 2:55 PM
Earnings season was in full swing this week, helping the Dow Jones Industrial Average (DJI) and Nasdaq Composite (IXIC) both log triple-digit gains right out of the gate, while the S&P 500 Index (S...
1/26/2023 9:06 AM
UBS downgraded Pfizer Inc. (NYSE:PFE) to "neutral" from "buy" this morning, citing lower Covid-19 expectations. The analyst also slashed its price target to $47 from $55, noting the pharmaceutical gi...
1/17/2023 9:28 AM
The brokerage bunch is busy this morning, with Pfizer Inc. (NYSE:PFE), Wendy's Co (NASDAQ:WEN), and Snap Inc (NYSE:SNAP) all receiving downgrades before today's open. Pfizer in Need of "Covid Res...
1/6/2023 1:25 PM
The dust has settled for 2022, but the new year hasn't gotten off to the start that a lot of investors were hoping for. The major indexes stumbled into 2023 with slight losses for the first session ...